TERN logo

Terns Pharmaceuticals, Inc. (TERN) Shareholders Equity

Annual Shareholders Equity:

$345.87M+$90.50M(+35.44%)
December 31, 2024

Summary

  • As of today, TERN annual stockholders equity is $345.87 million, with the most recent change of +$90.50 million (+35.44%) on December 31, 2024.
  • During the last 3 years, TERN annual shareholders equity has risen by +$185.57 million (+115.76%).
  • TERN annual shareholders equity is now at all-time high.

Performance

TERN Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTERNbalance sheet metrics

Quarterly Shareholders Equity:

$284.07M-$21.16M(-6.93%)
September 30, 2025

Summary

  • As of today, TERN quarterly stockholders equity is $284.07 million, with the most recent change of -$21.16 million (-6.93%) on September 30, 2025.
  • Over the past year, TERN quarterly shareholders equity has dropped by -$80.40 million (-22.06%).
  • TERN quarterly shareholders equity is now -22.06% below its all-time high of $364.47 million, reached on September 30, 2024.

Performance

TERN Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTERNbalance sheet metrics

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

TERN Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+35.4%-22.1%
3Y3 Years+115.8%+54.6%
5Y5 Years+8121.3%+314.1%

TERN Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+115.8%-22.1%+54.6%
5Y5-Yearat high+8121.3%-22.1%+314.1%
All-TimeAll-Timeat high+8121.3%-22.1%+6652.2%

TERN Shareholders Equity History

DateAnnualQuarterly
Sep 2025
-
$284.07M(-6.9%)
Jun 2025
-
$305.23M(-6.4%)
Mar 2025
-
$326.04M(-5.7%)
Dec 2024
$345.87M(+35.4%)
$345.87M(-5.1%)
Sep 2024
-
$364.47M(+66.7%)
Jun 2024
-
$218.68M(-7.6%)
Mar 2024
-
$236.72M(-7.3%)
Dec 2023
$255.37M(-7.8%)
$255.37M(-1.2%)
Sep 2023
-
$258.43M(-5.7%)
Jun 2023
-
$274.15M(-4.7%)
Mar 2023
-
$287.68M(+3.9%)
DateAnnualQuarterly
Dec 2022
$276.94M(+72.8%)
$276.94M(+50.8%)
Sep 2022
-
$183.69M(+33.9%)
Jun 2022
-
$137.22M(-7.7%)
Mar 2022
-
$148.72M(-7.2%)
Dec 2021
$160.30M(+133.7%)
$160.30M(-6.9%)
Sep 2021
-
$172.16M(-5.1%)
Jun 2021
-
$181.33M(-4.6%)
Mar 2021
-
$190.00M(+177.0%)
Dec 2020
$68.59M(+1530.4%)
$68.59M(+1530.4%)
Dec 2019
$4.21M(-94.2%)
$4.21M
Dec 2018
$72.23M
-

FAQ

  • What is Terns Pharmaceuticals, Inc. annual stockholders equity?
  • What is the all-time high annual shareholders equity for Terns Pharmaceuticals, Inc.?
  • What is Terns Pharmaceuticals, Inc. annual shareholders equity year-on-year change?
  • What is Terns Pharmaceuticals, Inc. quarterly stockholders equity?
  • What is the all-time high quarterly shareholders equity for Terns Pharmaceuticals, Inc.?
  • What is Terns Pharmaceuticals, Inc. quarterly shareholders equity year-on-year change?

What is Terns Pharmaceuticals, Inc. annual stockholders equity?

The current annual shareholders equity of TERN is $345.87M

What is the all-time high annual shareholders equity for Terns Pharmaceuticals, Inc.?

Terns Pharmaceuticals, Inc. all-time high annual stockholders equity is $345.87M

What is Terns Pharmaceuticals, Inc. annual shareholders equity year-on-year change?

Over the past year, TERN annual stockholders equity has changed by +$90.50M (+35.44%)

What is Terns Pharmaceuticals, Inc. quarterly stockholders equity?

The current quarterly shareholders equity of TERN is $284.07M

What is the all-time high quarterly shareholders equity for Terns Pharmaceuticals, Inc.?

Terns Pharmaceuticals, Inc. all-time high quarterly stockholders equity is $364.47M

What is Terns Pharmaceuticals, Inc. quarterly shareholders equity year-on-year change?

Over the past year, TERN quarterly stockholders equity has changed by -$80.40M (-22.06%)
On this page